On 15 December 2022, the DOH OIC-Secretary Maria Rosario Singh-Vergeire and DOST Secretary Renato Solidum, Jr. met to formally transfer the Health Technology Assessment Council (HTAC) and the Health Technology Assessment Division (HTAD) to the Department of Science and Technology (DOST) effective January 2023, following the provisions of the UHC act. This meeting was presided continue reading : HTA Division Meets with Department of Health (DOH) and Department of Science and Technology (DOST) Principals on Transition Concerns
Tugon ng HTAC sa mga Alegasyon sa Pagka-aksaya ng Mga Bakuna Kontra COVID-19
Ang a Health Technology Assessment Council (HTAC) ay naglabas ng paliwanag ukol sa paratang na ang HTAC ang dapat sisihin sa pagkasayang ng mga bakuna laban sa COVID 19. Ang rekomendasyon ng HTAC ay nagsisilbing gabay ng gobyerno sa paglalaan ng pondo ng Department of Health (DOH) at Philippine Health Insurance Corporation (PhilHealth). Sinusumite ng continue reading : Tugon ng HTAC sa mga Alegasyon sa Pagka-aksaya ng Mga Bakuna Kontra COVID-19
HTAC Response to Allegations on Wastage of COVID-19 Vaccines
The Health Technology Assessment Council (HTAC) issued a statement to respond to allegations that HTAC should be blamed for the wastage of COVID-19 vaccines. Vaccine wastage can be attributed to (1) non-use of vaccines because of public hesitancy and logistical problems, (2) over estimation in procurement due to inappropriate assumptions, and (3) misunderstanding of public continue reading : HTAC Response to Allegations on Wastage of COVID-19 Vaccines
DOH 19th National Health Research Forum for Action Kick Off Event
Representatives of the DOH HTA Division together with the HTA Council members, Subcommittee (SC) on Preventive and Promotive Health Chair Dr. Limuel Anthony Abrogena, SC on Clinical Equipment and Devices Chair Prof. Agnette Peralta, and SC on Medical and Surgical Procedures Chair Dr. Maria Minerva Calimag, attended the DOH 19th National Health Research Forum for continue reading : DOH 19th National Health Research Forum for Action Kick Off Event
HTAC Recommendation on the PNF Inclusion of Remdesivir for Adult Patients with COVID-19 Requiring Hospitalization
On 07 November 2022, the OIC-Secretary of Health (SOH) approved the Health Technology Assessment (HTAC) recommendation for the government financing of remdesivir (100mg lyophilized powder) for adult patients with COVID-19 requiring hospitalization through its inclusion in the Philippine National Formulary (PNF). This HTAC recommendation serves as an update of the interim HTAC recommendation on the procurement and/or continue reading : HTAC Recommendation on the PNF Inclusion of Remdesivir for Adult Patients with COVID-19 Requiring Hospitalization